Ho Chi Minh City

As the economic engine of Vietnam, Ho Chi Minh City (HCMC) has rapidly emerged as a premier life sciences hub in Southeast Asia, anchored by the strategic Saigon Hi-Tech Park (SHTP).

The city is best known for its robust pharmaceutical manufacturing capabilities, transitioning from generic production to high-value biopharmaceuticals and specialized oncology drugs.

With a burgeoning biotechnology sector, HCMC leads the nation in stem cell research, genomic resource management and the development of recombinant proteins via the dedicated HCMC Biotechnology Center.

The ecosystem is further bolstered by a sophisticated medical device market, attracting significant Foreign Direct Investment (FDI) for the production of advanced diagnostic imaging and surgical equipment.

Healthcare innovation is flourishing through a "dual transformation" strategy, integrating AI-driven diagnostics and digital health solutions into the city’s extensive hospital networks.

Renowned academic institutions, such as the University of Medicine and Pharmacy at HCMC, provide a steady pipeline of high-quality human capital while spearheading international clinical trials.

As the market value of Vietnam’s pharmaceutical industry climbs toward $10 billion, HCMC serves as the primary gateway for global investors seeking technology transfer opportunities and joint ventures.

The city's commitment to regulatory alignment and intellectual property commercialization makes it a competitive destination for R&D and specialized healthcare services.

Driven by an aging population and rising healthcare expenditure, Ho Chi Minh City is solidifying its position as a critical node in the global life sciences supply chain.